ANTI-GALECTIN-9 ANTIBODY AS A NOVEL TREATMENT OPTION IN RHEUMATOID ARTHRITIS TARGETING PATHOGENIC FIBROBLAST-LIKE SYNOVIOCYTES - Forskning - Aarhus Universitet

Aarhus Universitets segl

Til studerende
Til ph.d.er
Til medarbejdere
Institutter og fakulteter
Bibliotek
Presse

ANTI-GALECTIN-9 ANTIBODY AS A NOVEL TREATMENT OPTION IN RHEUMATOID ARTHRITIS TARGETING PATHOGENIC FIBROBLAST-LIKE SYNOVIOCYTES

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

DOI

https://doi.org/10.1136/annrheumdis-2019-eular.7092
Forlagets udgivne version

Ditte Koster, Aarhus Universitet
Malene Hvid
Aida Solhoj Hansen
Tue Wenzel Kragstrup
Pierre Busson, Univ Paris Saclay, Universite Paris Saclay, Universite Paris Sud - Paris 11, Universite Paris Saclay (ComUE), Centre National de la Recherche Scientifique (CNRS), Ecole Normale Superieure Paris-Saclay, CNRS, ENS Paris Saclay, Lab Aime Cotton,Univ Paris Sud
Bent Deleuran
Morten Aagaard Nielsen

Originalsprog	Engelsk
Udgivelsesår	jun. 2019
Antal sider	2
DOI	https://doi.org/10.1136/annrheumdis-2019-eular.7092
Status	Udgivet - jun. 2019
Eksternt udgivet	Ja
Begivenhed	Annual European Congress of Rheumatology (EULAR) - Madrid, Spanien Varighed: 12 jun. 2019 → 15 jun. 2019

Konference

Konference	Annual European Congress of Rheumatology (EULAR)
Land	Spanien
By	Madrid
Periode	12/06/2019 → 15/06/2019

Se relationer på Aarhus Universitet Citationsformater

ID: 188932636